about
Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft FunctionPharmGKB summary: cyclosporine and tacrolimus pathwaysThe use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.Review of the immunosuppressant enteric-coated mycophenolate sodium.Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation.Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortiumMonitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesThe role of tacrolimus in renal transplantation.Tacrolimus: review of pharmacokinetics, pharmacodynamics, and pharmacogenetics to facilitate practitioners' understanding and offer strategies for educating patients and promoting adherence.Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients.The safety of calcineurin inhibitors for kidney-transplant patients.A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.Drug interactions between the immunosuppressant tacrolimus and the cholesterol absorption inhibitor ezetimibe in healthy volunteers.Tacrolimus interaction with nafcillin resulting in significant decreases in tacrolimus concentrations: A case report.High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients.Investigation of clinical interaction between omeprazole and tacrolimus in CYP3A5 non-expressors, renal transplant recipients.Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.A randomized, crossover pharmacokinetic study comparing generic tacrolimus vs. the reference formulation in subpopulations of kidney transplant patients.Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors.Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research.Pharmacokinetics and Safety of Letermovir Coadministered With Cyclosporine A or Tacrolimus in Healthy Subjects.High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation.
P2860
Q28551398-3D830891-A073-4758-9298-A6F0907EC8BBQ33989902-D6919858-8D4D-4152-97AF-E511EDD2EA06Q35612903-DD34559C-8694-43CF-A453-94DA31FDFDF3Q35782898-1794699B-E2E4-442F-A9A5-DCD9CB418121Q35784063-3F582F5D-F684-48D2-A3D0-1208047AB16AQ36327259-70F959FC-D47F-42BF-BB95-9A4D18C293F5Q36630081-6F0713FE-6952-4A9E-A509-EA6B35E68904Q36724093-D405A0C1-901F-4BD6-9152-0E1248FB34A0Q37099023-E0988D36-138A-4A1E-8B3B-21DCF85F1238Q37610969-50839E77-7342-4CF3-A957-3899120291DBQ38417581-EE36B471-BEB2-4DC5-B916-0C5706B73395Q38578386-4B790030-3A08-4271-B6D0-4E994D567B8CQ38691788-AB4A53AC-C4D5-4864-8F7A-FC7EA5D13ACDQ39582716-FA4D949F-FF24-497E-9125-8986F11C20DEQ40379681-EFD02980-6F97-4E1B-8D36-379FFCB0CD43Q41217282-73303662-B30A-4621-A619-C7030B8E33ADQ41532194-48EA3D62-E62B-40A7-967C-3D60D390F3DBQ42612968-4B2C39E7-D68A-4EBC-9BE9-8EF718DDFDE1Q42622920-93EDEB90-CA11-49CB-8E4C-4340A3D667D6Q45105449-BA018764-0E9F-4872-8ABB-EADC08C8B4C5Q47306662-5FE4024A-B369-49D1-9E99-FF92EDF775FBQ47662522-C020902F-521D-4665-B0B8-A52E84D46B1FQ47771876-2D4B9A7D-EEC2-4461-8D24-0F30D65254DDQ53807644-8CD90B6F-7E7D-4141-8329-73BF3941F442Q55002551-0DC08292-54F9-4A11-B1FA-BF9FE71C37B2
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Drug interactions with tacrolimus.
@ast
Drug interactions with tacrolimus.
@en
Drug interactions with tacrolimus.
@nl
type
label
Drug interactions with tacrolimus.
@ast
Drug interactions with tacrolimus.
@en
Drug interactions with tacrolimus.
@nl
prefLabel
Drug interactions with tacrolimus.
@ast
Drug interactions with tacrolimus.
@en
Drug interactions with tacrolimus.
@nl
P1433
P1476
Drug interactions with tacrolimus.
@en
P2093
Teun van Gelder
P304
P356
10.2165/00002018-200225100-00003
P577
2002-01-01T00:00:00Z
P6179
1003537340